Article Details
Retrieved on: 2022-05-06 13:22:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“Since its approval, palbociclib has generated promising results for adults diagnosed with HR+, HER2- mBC, and this latest analysis reflects Pfizer's ...
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here